A drug interaction study of DUR-928 and Midozolam
Phase 1
Completed
- Conditions
- iver Disease
- Registration Number
- ACTRN12617000579392
- Lead Sponsor
- INC Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method